These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16569810)

  • 1. Pantoprazole-induced thrombocytopenia.
    Watson TD; Stark JE; Vesta KS
    Ann Pharmacother; 2006 Apr; 40(4):758-61. PubMed ID: 16569810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
    Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J; van Rensburg C; Vieweg W; Fischer R
    Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute interstitial nephritis due to pantoprazole.
    Ra A; Tobe SW
    Ann Pharmacother; 2004 Jan; 38(1):41-5. PubMed ID: 14742791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent anaphylaxis associated with pantoprazole.
    Gratacós L; Soy D; Lluís M; López B; Nicolás JM; Codina C; Nogué S; Ribas J
    Am J Health Syst Pharm; 2005 Jul; 62(13):1388-9. PubMed ID: 15972383
    [No Abstract]   [Full Text] [Related]  

  • 6. [2 new proton pump inhibitors. Possibilities of pantoprazole and lansoprazole].
    Leonhardt U; Ritzel U; Ramadori G
    Internist (Berl); 1996 Sep; 37(9):944-9; discussion 949. PubMed ID: 8964694
    [No Abstract]   [Full Text] [Related]  

  • 7. Pantoprazole-induced acute interstitial nephritis.
    Moore I; Sayer JA; Nayar A; Ahmed S; Tapson JS
    J Nephrol; 2004; 17(4):580-1. PubMed ID: 15372423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer.
    Beker JA; Bianchi Porro G; Bigard MA; Delle Fave G; Devis G; Gouerou H; Maier C
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):407-10. PubMed ID: 7614102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies.
    Bardhan KD; Cherian P; Bishop AE; Polak JM; Romanska H; Perry MJ; Rowland A; Thompson M; Morris P; Schneider A; Fischer R; Ng W; Lühmann R; McCaldin B
    Am J Gastroenterol; 2001 Jun; 96(6):1767-76. PubMed ID: 11419827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pantoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Takac B; Ivandić A; Pezerović D; Horvat D; Nedić P; Kotromanović Z; Maksimović Z; Vranjes Z; Males J; Jurisić-Orzen D; Vladika I; Stimac T; Mandić B
    Acta Med Croatica; 1999; 53(2):79-82. PubMed ID: 10705625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole.
    Schepp W; Rehner M; Witzel L
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():53-7. PubMed ID: 8180295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Dupas JL; Houcke P; Samoyeau R;
    Gastroenterol Clin Biol; 2001 Mar; 25(3):245-50. PubMed ID: 11395670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
    Giannini E; Romagnoli P; Fasoli A; Chiarbonello B; Malfatti F; Botta F; Risso D; Lantieri PB; Savarino V; Testa R
    Am J Gastroenterol; 2000 Oct; 95(10):2762-7. PubMed ID: 11051345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole.
    Regula J; Butruk E; Dekkers CP; de Boer SY; Raps D; Simon L; Terjung A; Thomas KB; Lühmann R; Fischer R
    Am J Gastroenterol; 2006 Aug; 101(8):1747-55. PubMed ID: 16817839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis.
    Sennaroglu E; Karakan S; Kayatas M; Akdur S; Genc H; Karakan T; Ucler R; Ozisler C; Urun Y
    Dig Dis Sci; 2006 Jan; 51(1):121-2. PubMed ID: 16416223
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of proton pump inhibitors--an overview.
    Arnold R
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():65-70. PubMed ID: 8180297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton-pump inhibitors: three of a kind?
    Bateman DN
    Lancet; 1997 Jun; 349(9066):1637-8. PubMed ID: 9186377
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole.
    Härtter S; Connemann B; Schönfeldt-Lecuona C; Sachse J; Hiemke C
    J Clin Psychopharmacol; 2004 Oct; 24(5):568-71. PubMed ID: 15349025
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
    Ramdani A; Mignon M; Samoyeau R
    Gastroenterol Clin Biol; 2002 Apr; 26(4):355-9. PubMed ID: 12070410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug interactions. Proton pump inhibitors II].
    Zaigler M
    Internist (Berl); 1998 Sep; 39(9):978-9. PubMed ID: 9788120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.